Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.23 | 20.17 |
| PEG Ratio (TTM) | 3.59 | -10.19 |
| P/S Ratio (TTM) | 0.75 | 2.88 |
| P/B Ratio (TTM) | 1.27 | 7.28 |
| P/FCF Ratio (TTM) | -30.67 | 28.64 |
| Price to 5YR AVG Earnings Ratio | 30.53 | 10.62 |
| Price to 5YR AVG FCF Ratio | 41.62 | 19.20 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.81% | 7.92% |
| ROE (TTM) | 5.65% | 44.40% |
| Net Profit Margin (TTM) | 3.38% | 12.99% |
| ROIC 5YR AVG | 4.90% | 19.00% |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -414.58% | -117.51% | -235.24% |
| Revenue | 2.59% | 10.82% | 9.27% |
| Net Income | -61.16% | -150.02% | 34.63% |
| Cash Flow | -25.31% | 13.28% | 58.94% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.18 | 1.60 |
| Quick Ratio (TTM) | 1.65 | 1.17 |
| D/E Ratio (TTM) | 1.46 | 1.79 |
| Interest Coverage (TTM) | 0.93 | 3.44 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.34 | 3.50 |
| LTL to 5YR AVG FCF | 43.41 | 3.99 |
| Shares Outstanding Growth 5YR AVG | 3.82% | -1.08% |